🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Zacks.com Featured Highlights: Ligand Pharmaceuticals, Ormat Technologies, Activision Blizzard, Boise Cascade And Ubiquiti Networks

Published 08/11/2016, 09:30 PM
Updated 07/09/2023, 06:31 AM
US500
-
ATVI
-

For Immediate Release

Chicago, IL – August 12, 2016 - Stocks in this week’s article include: Ligand Pharmaceuticals Inc. (LGND), Ormat Technologies, Inc. (ORA), Activision Blizzard (NASDAQ:ATVI), Inc. (ATVI), Boise Cascade Company ( BCC) and Ubiquiti Networks, Inc. (UBNT).

Screen of the Week of Zacks Investment Research:

5 Stocks to Play Momentum the Driehaus Way

Momentum strategies that have the potential to offer healthy returns have always been the on radar of investors with a high risk appetite. The principle is "buy high and sell higher." Richard Driehaus is a pioneer investor who created profit-making strategies based on this philosophy. Barron paid tribute to Driehaus by including him in its All-Century Team.

Some of the investing institutions such as the American Association of Individual Investors (AAII) applied Driehaus’ momentum strategy to build up portfolios that bore fruit. A portfolio following this strategy provided returns of 13.5% and 18.1% in the five- and 10- year timeframe, respectively, in contrast to -1.1% and 4.2% returns registered by the S&P 500, as per AAII.

Investing the Driehaus Way

After a detailed study of Driehaus’ strategy, AAII concluded that it mainly focuses on strong earnings growth rates and impressive prospects of delivering the same in the future in order to pick potential companies. While this strategy was made to provide better returns over longer time frames, companies with a strong history of beating estimates are also given importance in this strategy.

“I would much rather invest in a stock that’s increasing in price and take the risk that it may begin to decline than invest in a stock that’s already in a decline and try to guess when it will turn around,” Driehaus said in an interview.

Screening Parameters

The percentage 50-day moving average is one of the key criteria in this strategy. A positive percentage 50-day moving average indicates that the stock is trading at a price higher than its 50-day moving average level, indicating an uptrend. It is calculated by dividing the numerator (month-end price minus 50-day moving average of month-end price) by the 50-day moving average of the month-end price. Another momentum indicator – positive relative strength – has also been included in this strategy.

In order to make the strategy more profitable, we have only considered only those stocks that have a Zacks Rank #1 (Strong Buy) or 2 (Buy) as well as a momentum score of ‘A’. Our research shows that stocks with a Style Score of ‘A’ or ‘B’ when combined with a Zacks Rank #1 or 2 offer the best upside potential.

• Zacks Rank equal to or less than #2
(Only Strong Buy and Buy rated stocks can get through.)

Last 5-year average EPS growth rates above 2%
(Strong EPS growth history ensures improving business.)

Trailing 12 month EPS growth higher than 0 and industry median
(Higher EPS growth compared to the industry average indicates superior stocks.)

Last four-quarter average EPS surprise greater than 5
(Positive EPS surprise indicates potential.)

Positive % 50-day moving average and relative strength over 4 weeks
(High % 50-day moving average and relative strength signal uptrend.)

Momentum Score equal to A
(Favorable momentum score indicates that it is ideal to take advantage of the momentum with the highest probability of success.)

Just these few criteria narrowed down the universe of over 7,700 stocks to only 13.

Here are five of the 13 stocks:

Ligand Pharmaceuticals Inc. (LGND) discovers, develops and markets new drugs that address critical unmet medical needs of patients. In addition to a Zacks Rank #1, Ligand also has an average four-quarter positive earnings surprise of 36.7%.

Ormat Technologies, Inc. (ORA) brings three decades of experience in the development, manufacture and marketing of innovative power systems. In addition to a Zacks Rank #1, Ormat has an average four-quarter positive earnings surprise of 21.3%.

Activision Blizzard, Inc. (ATVI) is a worldwide pure-play online and console game publisher with leading market positions across all categories of the rapidly growing interactive entertainment software industry. In addition to a Zacks Rank #2, Activision Blizzard also has an average four-quarter positive earnings surprise of 33.5%.

Boise Cascade Company (BCC) operates as a wood products manufacturer and building materials distributor. In addition to a Zacks Rank #2, Boise Cascade also has an average four-quarter positive earnings surprise of more than 100%.

Ubiquiti Networks, Inc. (UBNT) is engaged in the business of designing, manufacturing and selling broadband wireless solutions worldwide. In addition to a Zacks Rank #2, Boise Cascade has an average four-quarter positive earnings surprise of 13.2%.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today .

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance .

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don’t wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=111

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com

Visit: https://www.zacks.com/performance

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer .

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.



LIGAND PHARMA-B (LGND): Free Stock Analysis Report

ORMAT TECH INC (ORA): Free Stock Analysis Report

ACTIVISION BLZD (ATVI): Free Stock Analysis Report

BOISE CASCADE (BCC): Free Stock Analysis Report

UBIQUITI NETWRK (UBNT): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.